As of Jan 23
| -0.16 / -2.16%|
The 3 analysts offering 12-month price forecasts for Corcept Therapeutics Inc have a median target of 7.00, with a high estimate of 12.00 and a low estimate of 5.00. The median estimate represents a -3.31% decrease from the last price of 7.24.
The current consensus among 3 polled investment analysts is to Buy stock in Corcept Therapeutics Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.